Home › NDC Lookup › Drug shortages › Morphine Sulfate Tablet

Morphine Sulfate Tablet shortage

Morphine Sulfate Tablet is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 25, 2026.

To Be Discontinued ⚠ Supply risk: High Controlled substance Analgesia/Addiction 2 products 277 days First posted Dec 22, 2025 Updated Dec 22, 2025
Here’s the bottom line

Upsher-Smith is permanently stopping its morphine sulfate tablets (both 15 mg and 30 mg). Other makers — Hikma, SpecGx, and Major Pharmaceuticals — still list both strengths as available.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
2
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/2
Affected strengths supplied
277
Days in shortage
10,803
Medicaid Rx (2025)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 25, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Morphine Sulfate Tablet. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
2 NDCs
To be discontinued 2
Affected strengths still supplied
Among manufacturers reporting this shortage
0/2 strengths
No supply 2
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Morphine Sulfate Tablet from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Hikma Pharmaceuticals USA Inc. SpecGx LLC Major Pharmaceuticals
Plus 17 alternative dosage forms of Morphine Sulfate.
See all other options & details →
Shortage timeline
  1. Dec 22, 2025
    Currently in shortage
    2 of 2 products affected.
  2. Dec 22, 2025
    First reported to the FDA
    2 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Upsher-Smith Laboratories, LLC 📞 763-315-2000 2 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11) NDC 00832-0273-11 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11) NDC 00832-0274-11 — — Discontinuation of the manufacture of the drug —

These rows are manufacturer reports to the FDA for Morphine Sulfate Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Morphine Sulfate Tablet? options further down this page.

Why is Morphine Sulfate Tablet in shortage?

Upsher-Smith Laboratories has decided to permanently stop making their morphine sulfate tablets altogether. This affects both their 15 mg and 30 mg tablet versions — they will no longer be manufacturing either of those products going forward.

It's worth knowing that this report only covers what Upsher-Smith has shared with the FDA about their own products. No specific reason was given publicly for why they made this business decision — just that manufacturing of these two strengths is being discontinued by them.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Morphine Sulfate Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Morphine Sulfate Tablet?

Morphine Sulfate tablets are currently on the FDA drug-shortage list. I want to walk you through what this means so you can plan your next steps calmly.

The report covers two strengths: the 15 mg and 30 mg tablets, and both are affected right now with no available source reported. This shortage record reflects one manufacturer, Upsher-Smith Laboratories, and the reason listed for both strengths is that the company is discontinuing the manufacture of the drug. Because this is a discontinuation rather than a temporary delay, the supply problem from this maker may be permanent, so a conversation with your prescriber is the right next step.

It's important to know this report reflects only one manufacturer. The same medicine — morphine sulfate tablets in both 15 mg and 30 mg — is still on the market from other makers, including Hikma Pharmaceuticals and SpecGx.

Here is what I suggest:

  1. Do not stop, skip, or change your dose on your own.
  2. Ask your pharmacy whether they can source the same medicine from another maker (such as Hikma or SpecGx); it may not be in local stock but can often be ordered.
  3. If it cannot be found, ask your prescriber or pharmacist about options.

Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls.

This is general, national information and may not match your local pharmacy's actual stock.

See “Where else can I get Morphine Sulfate Tablet?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
  • This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Keep reading
Our full Morphine guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Morphine guide →

Where else can I get Morphine Sulfate Tablet?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Morphine Sulfate Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Morphine Sulfate MORPHINE SULFATE 15 mg/1 Tablet · Oral Hikma Pharmaceuticals USA Inc. 00054-0235-24
Morphine Sulfate MORPHINE SULFATE 30 mg/1 Tablet · Oral Hikma Pharmaceuticals USA Inc. 00054-0236-24
Morphine Sulfate MORPHINE SULFATE 15 mg/1 Tablet · Oral SpecGx LLC 00406-5118-01
Morphine Sulfate MORPHINE SULFATE 30 mg/1 Tablet · Oral SpecGx LLC 00406-5119-01
Morphine Sulfate MORPHINE SULFATE 15 mg/1 Tablet, Extended Release · Oral SpecGx LLC 00406-8315-01
Morphine Sulfate MORPHINE SULFATE 200 mg/1 Tablet, Extended Release · Oral SpecGx LLC 00406-8320-01
Morphine Sulfate MORPHINE SULFATE 30 mg/1 Tablet, Extended Release · Oral SpecGx LLC 00406-8330-01
Morphine Sulfate MORPHINE SULFATE 60 mg/1 Tablet, Extended Release · Oral SpecGx LLC 00406-8380-01
Morphine Sulfate MORPHINE SULFATE 100 mg/1 Tablet, Extended Release · Oral SpecGx LLC 00406-8390-01
Morphine Sulfate Extended Release MORPHINE SULFATE 15 mg/1 Tablet, Film Coated, Extended Release · Oral Major Pharmaceuticals 00904-6557-61
Morphine Sulfate Extended Release MORPHINE SULFATE 30 mg/1 Tablet, Film Coated, Extended Release · Oral Major Pharmaceuticals 00904-6558-61
Morphine Sulfate Extended Release MORPHINE SULFATE 60 mg/1 Tablet, Film Coated, Extended Release · Oral Major Pharmaceuticals 00904-6559-61

Alternative dosage forms of Morphine Sulfate

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 16 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Morphine Sulfate 15 mgNDC 00054-0235-24 Hikma 100 tablets $0.226 AB Discontinued
Morphine Sulfate 15 mgNDC 00406-5118-01 SpecGx 100 tablets $0.226 AB Availability likely
Morphine Sulfate 15 mgNDC 00832-0273-11 Upsher-Smith 100 tablets $0.226 AB Availability likely
Morphine Sulfate 15 mgNDC 60687-0617-01 American 100 tablets $0.226 AB Availability likely
Morphine Sulfate 15 mgNDC 67877-0670-01 Ascend 100 tablets $0.226 AB Availability likely
Morphine Sulfate 30 mgNDC 00054-0236-24 Hikma 100 tablets $0.341 AB Discontinued
Morphine Sulfate 30 mgNDC 00406-5119-01 SpecGx 100 tablets $0.341 AB Availability likely
Morphine Sulfate 30 mgNDC 00832-0274-11 Upsher-Smith 100 tablets $0.341 AB Availability likely
Morphine Sulfate 30 mgNDC 67877-0671-01 Ascend 100 tablets $0.341 AB Availability likely
MS Contin 15 mgNDC 42858-0515-01 Rhodes 100 tablets $4.653 +1963% AB Availability likely
MS Contin 30 mgNDC 42858-0631-01 Rhodes 100 tablets $8.948 +2521% AB Availability likely
Morphine Sulfate 15 mgNDC 63629-8459-01 Bryant 100 tablets — AB FDA listed
Morphine Sulfate 15 mgNDC 67296-1753-01 RedPharm 10 tablets — AB Discontinued
Morphine Sulfate 15 mgNDC 67296-2122-06 Redpharm 6 tablets — AB FDA listed
Morphine Sulfate 15 mgNDC 60760-0893-60 St. 60 tablets — AB FDA listed
Morphine Sulfate 30 mgNDC 71335-9662-01 Bryant 60 tablets — AB FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Morphine Sulfate Tablet — that fall in the same broad treatment class (opioid analgesics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 004091
GCN 16070
HICL code 001694
Ingredient (HICL) Morphine Sulfate
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H3
Therapeutic class — intermediate (HIC2) Analgesics
HIC3 code H3A
Therapeutic class — specific (HIC3) Opioid Analgesics
AHFS code 28:08.08.00
AHFS class Opioid Agonists (28:08)
FDB label name MORPHINE SULFATE IR 15 MG TAB
FDB brand name Morphine Sulfate
Legend status F — Federal legend — prescription drug or device
GPI-1465100055100310
GPI classMorphine Sulfate
DEA scheduleCII
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other analgesia/addiction shortages

Morphine Sulfate Tablet shortage FAQs

Is Morphine Sulfate Tablet in shortage?
Yes — the FDA currently lists Morphine Sulfate Tablet in shortage (status: “To Be Discontinued”, first reported Dec 22, 2025). 2 of 2 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11) (NDC 00832-0273-11); Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11) (NDC 00832-0274-11). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Morphine Sulfate Tablet be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Morphine Sulfate somewhere?
Other manufacturers (Hikma Pharmaceuticals USA Inc., SpecGx LLC, Major Pharmaceuticals) still market it and have not reported a shortage. 17 alternative dosage forms of Morphine Sulfate are also listed. See “Where else can I get Morphine Sulfate Tablet?” above — stock still varies by pharmacy.
What should I do if I take Morphine Sulfate Tablet?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out. Because this is a controlled substance, transfers and substitutions have extra federal/state rules — ask the pharmacy first.

Still have a question about the Morphine Sulfate Tablet shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages